Trial Profile
Drug disposition in the human colon: sampling optimization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2022
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Pharmacokinetics
- 19 Oct 2022 Status changed from recruiting to completed.
- 20 Aug 2018 New trial record